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Abstract
Background: Shared decision making (SDM) is recognized as a person-centered approach to improving health care quality
and outcomes. Few digital interventions to improve SDM have been tested in child and adolescent mental health (CAMH) settings.
One such intervention is Power Up, a mobile phone app for young people (YP), which has shown some evidence of promise that
YP who received Power Up reported greater levels of SDM. However, even though parents play a critical role in CAMH care
and treatment, they often feel excluded from services.
Objective: This protocol is for a pilot trial to determine the feasibility of a large-scale randomized trial to develop and evaluate
a Web app (called Power Up for Parents, PUfP) to support parents and promote involvement in CAMH decisions.
Methods: A 2-stage process, consisting of the development stage and pilot-testing stage of the initial PUfP prototype, will be
conducted. At the development stage, a qualitative study with parents and clinicians will be conducted. The interviews will aim
to capture the experience of making CAMH decisions, preferences for involvement in SDM, and determine situations within
which PUfP can be useful. At the pilot-testing stage, up to 90 parents and their clinicians will be invited to participate in the
testing of the prototype. Parents will be randomly allocated to receive the intervention or be part of the control group. This study
design will allow us to assess the acceptability and usefulness of PUfP in addition to examining the feasibility of a prospective
randomized trial. Clinicians’ perceptions of the prototype and how it has influenced parents’ involvement in SDM will also be
examined.
Results: Recruitment began in January 2019 and is scheduled to last for 10 months. Interviews and baseline data collection are
currently in progress. To date, 11 CAMH sites have been recruited to take part in the study. It is anticipated that data collection
will be completed by October 2019.
Conclusions: The lack of parents’ involvement in CAMH care and treatment can lead to higher rates of dropout from care and
lower adherence to therapeutic interventions. There are significant benefits to be gained globally if digital SDM interventions
are adopted by parents and shown to be successful in CAMH settings.
Trial Registration: International Standard Randomized Controlled Trial Number (ISRCTN): 39238984;
http://www.isrctn.com/ISRCTN39238984.
International Registered Report Identifier (IRRID): DERR1-10.2196/14571
(JMIR Res Protoc 2019;8(7):e14571)   doi:10.2196/14571
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Introduction
Background
Worldwide, up to 20% of children and adolescents suffer from
a disabling mental illness [1,2]. In England alone, 1 in 8 (12.8%)
of 5 to 19 year olds have at least one mental health disorder [3].
As a result, families are faced with many decisions, such as
how, when, and where to seek help [4]; agreeing on treatment
options when more than 1 treatment option is available [5,6];
agreeing on the goals of treatment [7,8]; and agreeing on the
diagnostic tests [9]. However, making decisions for young
people (YP) with mental health problems can be challenging,
as evident by the high levels of disagreement between parents,
YP, and clinicians [10-21]. Researchers and practitioners suggest
that the implementation of shared decision making (SDM) in
child and adolescent mental health services (CAMHS) can be
one approach to reduce treatment disagreements [22] and
successfully manage the decision-making process that involves
balancing multiple perspectives [23,24].
SDM is recognized as a person-centered approach to improving
health care quality and outcomes and has been advocated across
many health settings, including child and adolescent mental
health (CAMH) [23,25,26]. SDM is defined as the
communication process that allows service users and service
providers to collaborate when making care and treatment
decisions [27]. Although there is an increasing demand to
include SDM in health care in support of a person-centered
approach, attempting to do this in CAMH settings has been met
with particular challenges [28].
In adult settings, decisions are usually made between the patient
and the clinician or, in the case of a triad, the carer is usually
another adult. In CAMH settings, the SDM process is unique
as it involves a sometimes-complex triad relationship [27,29]
between clinicians, children, and parents. Previous studies have
mainly focused on the dyad relationships between physicians
and patients; therefore, the areas where triad relationships exist
have been less understood. When implementing SDM in CAMH,
clinicians are forced to moderate highly stressed parents and
children and have complex conversations [23].
Researchers highlight common emotional states such as anxiety,
distress, sadness, and worry among families involving a child
with a mental illness [30-33]. Parents as primary care providers
must adopt the responsibilities of caring for a child with mental
challenges, which affects their own quality of life [34-36]. Yet,
many studies show that parents feel stigmatized and excluded
from services [35,37]. Parents feel as if they lack the necessary
support from services to help them with supporting their
sometimes-unstable child. However, the SDM literature is scarce
on whether these emotional factors positively or negatively
impact parental decision-making involvement.
As parents are expected to play a critical role in care and
treatment, for example, as copatients (family therapy) or as
cotherapists (cognitive behavioral therapy), or be the direct
focus of the intervention (parent training) [38,39], it is crucial
that these parents are involved in the decision-making process.
Studies show that involving service users in CAMH care and
treatment decisions is associated with improved health outcomes
[40] and higher satisfaction with services [41]. Therefore,
parents need support to play an active role in the
decision-making process.
Improving SDM in CAMH settings can be accomplished when
there is an understanding of the factors impacting how parents
make or wish to make intervention or care decisions, and when
clinicians are able to offer the necessary support for families to
be involved in this type of decision making process. SDM
includes the notion of a medical encounter as a meeting of
experts —the physician as an expert in medicine and the
patient/parent as an expert in his or her own life, values, and
circumstances [42]. British law states that decisions should be
made with the child’s best interest at heart [43]. Therefore, the
decision needs of parents and children should be addressed to
accomplish quality decisions, where the quality of the decision
is judged as good if there is consistency with the decision
maker’s own values and satisfaction with the decisions made
while participating in SDM [44].
Rationale
The prevalence and burden of CAMH on the National Health
Service (NHS) is substantial, and supporting large numbers of
families at face-to-face sessions can be a challenge [45];
therefore, the use of digital technology can increase access to
interventions [46,47]. Mobile technology (ie, mobile phones,
tablets, and laptops) use has been on the rise and is estimated
to reach 6.1 billion users by 2020 [48]. This offers the
opportunity to take advantage of mobile health (mHealth).
mHealth is the general term for the use of mobile phones and
other wireless technology in clinical practice [49]. Despite the
growing number of mHealth apps, the level of awareness and
usability of such apps by patients are reported as still relatively
low. Nevertheless, the majority of those who use health apps
find them to be beneficial and helpful for living a healthier
lifestyle [50].
Power Up is an app, co-designed with YP, to empower YP to
take an active role in SDM. Power Up has received positive
findings, with YP reporting greater levels of SDM after the
intervention period [51]. Building on Power Up, this study aims
to involve end users in the development of an intervention,
called Power Up for Parents (PUfP), to promote SDM and
support parents of children and YP accessing CAMHS.
Research Questions
The primary research aim for this feasibility study is to develop
and investigate whether it is feasible and acceptable to conduct
a prospective randomized controlled trial (RCT) of an
evidence-based mobile app to promote SDM in families
accessing CAMHS.
The following research questions will be addressed:
1. Is PUfP acceptable and useful for parents and health care
professionals?
2. What is the eligibility, participant consenting rates,
adherence, and engagement rates of participants using
PUfP?
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3. Are the outcome measures appropriate and acceptable for
a prospective RCT?
4. What are the potential barriers and enablers to conducting
a prospective RCT?
5. Which data collection procedures are appropriate and
acceptable?
6. What is the scope of the pilot data collected from users and
nonusers of PUfP?
7. Can the feedback from PUfP users be used to further refine
the prototype for the prospective RCT?
Methods
Design
This a 2-stage study involving a development stage (stage 1)
where the intervention will be user-tested by clinicians and
parents, and suggestions will be obtained for usage and
upgrading of the prototype. The pilot-testing stage (stage 2) is
a 3-arm, cluster randomized pilot trial with parents accessing
CAMHS.
Study Setting
The study team has identified CAMH sites from 18 NHS trusts
throughout England. The study team identified and agreed to
use 9 London and 9 non-London sites. CAMHS is being used
as a broad term for all services that work with children and YP
who are experiencing mental health challenges. However, the
focus centers around, but is not limited to, specialist CAMHS,
where children and YP receive services from a multidisciplinary
team that includes psychologists and psychiatrists.
Intervention: Power Up for Parents
The PUfP app is an amended version of the original Power Up
app that supports and promotes SDM in CAMH settings. The
original Power Up is a mobile app used by YP to empower and
encourage them to take an active role in the decision-making
process [52,53].
The development of the PUfP prototype was guided by the
Workbook for Developing and Evaluating Patient Decision
Aids [54] and the Ottawa Decision Support Framework [55].
The prototype (see Figure 1) was informed by a scoping review
of existing parent-targeted SDM interventions used in CAMH.
A further systematic review was conducted to inform the content
of PUfP. We consulted the National Children’s Bureau Families
Research Advisory Group (FRAG) to obtain input on the study
design and how to improve the intervention before the study
began. A steering committee involving parents with experience
of having a child with mental health problems and the digital
lead at the Anna Freud National Centre for Children and
Families (AFNCCF) also offered input on the design of PUfP.
The content will be screened by various parent groups and
professionals before being used in the pilot study. The overall
structure of the app’s content is as follows.
Figure 1. The home screen.
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Figure 2. The decision tab.
Decision
This is a decision aid that guides users to seek information about
treatment options and the benefits and risks of each option, to
track decisions, and to record where more information or support
is needed. In addition, as this is a triad relationship, users will
be prompted to involve others in the decision-making process
by seeking preferences from clinicians, child, or other
appropriate persons (see Figure 2).
Goal
This feature can be used in sessions or between sessions to
record and track goals as they are discussed with health care
professionals and the child. This will allow users to plan and
record any questions or concerns they have so that they can
address them at the next session (see Figure 3.
Journey
This feature allows parents to reflect on their emotions or issues
that may be affecting the decision-making process. A parent
can decide to share this content with the child and the clinician,
and it can be used during and within sessions to keep track of
the decision-making journey from user readiness to outcomes.
Expectations, experiences, and reflections can all be recorded
here using the diary function (see Figure 4).
Support
This section will host a tool to allow parents to identify and
express views about various stressors affecting the
decision-making process. Users will be able to think about things
that are stressful and explore ways to manage these. They can
track feelings about decisions and explore where additional
emotional support is required (see Figure 5).
Resources
This section includes useful contact details that can signpost
users to further support and guidance. Parents can also upload
their own resources to help with the decision-making process
and include contacts that they find most helpful (see Figure 6).
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Figure 3. The goal tab.
Figure 4. The journey tab.
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Figure 5. The support tab.
Figure 6. The resources tab.
Recruitment
Clinicians
All clinicians at the selected NHS sites will be invited to an
information session where they will receive information about
the study and be given the opportunity to further assist in
developing the inclusion criteria for parent participants and
inform the recruitment process. This will allow interested
clinicians to identify themselves to the research team and
become early active participants in the trial. Clinicians for the
purpose of this study will support the recruitment process by
identifying parent participants within their practice and also, as
participants themselves, to inform the development of PUfP
and provide feedback on its impact.
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Parents
On the basis of the inclusion/exclusion criteria agreed at the
information session, clinicians will strategically scan their
patient list and select suitable participants. At a subsequent
meeting with the families, clinicians will solicit interest in
participation by sharing some information about the aims of the
study. If the family expresses interest in taking part, their contact
details will be added to the site’s database of potential
participants. The key person at the site will supply the researcher
with the database of contact details to invite the parents to
participate.
Posters will be placed at participating NHS sites, and parents
can also voluntarily contact researchers to express interest in
participating. Various parent groups will also advertise the
study; therefore, parents may also contact researchers without
being identified by clinicians. In addition, the research team
will visit the selected CAMHS to recruit participants on clinic
days. All parents will be screened to ensure they meet the
inclusion criteria. The preliminary inclusion/exclusion criteria
are given below.
The inclusion criteria included the following:
1. Over the age of 18 years
2. No known diagnosed mental health issues
3. Ability to speak and understand English
4. Parent of at least one young person (>11 years) attending
CAMHS
The exclusion criteria included the following:
1. Concurrent and/or involvement in other research that is
likely to interfere with the intervention
2. Parents or guardians in cases where the child/young person
is being treated under a section of the Mental Health Act
Patient and Public Involvement
Patient and public involvement (PPI) will be conducted
throughout the development of PUfP. The opinions and guidance
of parent experts and clinicians will be obtained through
consultations on the content and the design of the app. We
conducted a 3-part consultation session with the FRAG. First,
an email consultation round was conducted where the FRAG
provided input on the value of PUfP and identified groups of
parents that the research team should target for recruitment.
Then, the study design and an example of how the intervention
might be used were presented to the group. The pros and cons
of various modalities for PUfP were discussed along with
general thoughts and concerns on the study design. At the final
consultation, parents further discussed how service users could
use and benefit from the PUfP in practice.
Procedure and Materials
NHS sites were identified through consultations with supervisors
and other researchers at the AFNCCF and University College
London (UCL). CAMHS were recruited from across England,
and a key contact person was identified at each site. The contact
person will circulate information about the study to all clinicians.
Then clinicians will be invited to an information session where
they will receive further information about the study. The team
will then begin to identify suitable participants already accessing
their services based on the inclusion/exclusion criteria further
developed at this session. This will be a transparent process
where clinicians will scan their patient list and select suitable
participants.
Clinicians will then inquire if the selected families are interested
in the study and add them to the site’s database of interested
participants. Each clinician can continue to add names to the
database, and the key contact will provide the updated list of
interested participants with their respective contact details as
new participants are recruited.
In addition, researchers will attend clinics to distribute flyers
and recruit onsite volunteer participants. Parent support groups
at the CAMHS services will also be approached, and parents
will be given the opportunity to volunteer as participants after
information about the study is shared. These forms of
recruitment will be guided and informed by PPI participants
(parent networks) whose expertise is being sourced to inform
the recruitment process.
Stage 1 (Development Stage)
This stage will involve semistructured interviews and focus
groups to obtain qualitative data for the design and content of
the PUfP prototype. All participants (ie, clinicians and parents)
will be sent information sheets and consent forms in advance
of the interviews and focus groups. In addition to gathering
parents’ experiences of decision making in CAMHS, an existing
prototype of PUfP will be presented, and suggestions for content
and prototype upgrades will be obtained. Focus groups are
expected to last up to 90 minutes and interviews (phone or face
to face) to last up to 1 hour. The aim is to achieve saturation or
involve a minimum sample of 12 interviews or 2 focus group
discussions per group [56,57]. After the first 10 interviews,
saturation for this study is reached once no new material
emerges after further 3 consecutive interviews [58].
In the focus groups and interviews, participants will review the
current prototype on materials supplied by the researcher.
Feedback on all aspects of the prototype will be requested, and
questions about the additional support needs and
recommendations for the upgrade will be asked. In addition,
the usefulness of the intervention and preference for modality
will be sought. At the end of the focus groups and interviews,
participants will be debriefed and advised to contact researchers
with any further questions or suggestions via our contact details
previously given on the information sheets.
Stage 2 (Pilot-Testing Stage)
The 18 sites identified will be randomly assigned to either
control or 1 of the 2 intervention groups. Intervention group 1
(IG1) will receive the prospective version 1 of PUfP, which
includes the Support and Resources features. Intervention group
2 (IG2) will receive version 2 of PUfP without these 2 features.
The cluster randomization was completed independently of the
research team, using R software guided by the balance algorithm
[59]. Participant-level randomization will not be conducted for
this study and parents at all selected sites will have a chance to
participate in the study. The Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT) diagram
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(see Table 1) and flow diagram (see Multimedia Appendix 1)
illustrates the pathway through the trial, based on the trial
protocol (version 1.3, November 14, 2018) approved by the
NHS Research Ethics Committee and the Health Research
Authority.
Table 1. SPIRIT diagram for the Power Up for Parents feasibility trial.
Study periodTime point
End of StudyPosttestInterventionPretestEnrollment
———
—
bXaEligibility screen
————XInformed consent
————XAllocation
—————Interventions
XXX——Intervention Group 1
XXX——Intervention Group 2
X————Control Group
—————Assessments
XXXXXFeasibility outcomes
—X—X—CPS-Pc
—X—X—PSDM-Q-Parentd
—X—X—STAI-ADe
—X—X—DCSf
—X—X—ESQg
—X———PSSUQh
aSchedule and time commitment for trial participants.
bNot applicable.
cCPS-P: Control Preferences Scale for Pediatrics.
dPSDM-Q-Pediatric Shared Decision-Making Questionnaire.
eSTAI-AD: Spielberger State Anxiety Inventory Form for Adults.
fDCS: Decisional Conflict Scale.
gESQ: Experience of Service Questionnaire.
hPSSUQ: Post-Study Usability Questionnaire.
Stage 2 involves reinviting previous participants and obtaining
informed consent from all the participants. Participants will be
identified and recruited in identical ways as in the development
stage. Participants will then be assigned to use the prototype
and give feedback on usefulness, usability, and acceptability of
the intervention. Up to 90 parents, and their respective clinicians,
will be invited to participate in this stage with approximately
30 being allocated version 1 of PUfP, another 30 being allocated
version 2, and the remaining 30 as the control group, receiving
no app but subject to the same battery of questionnaires and
treatment as usual. A sample ranging from 10 to 30 per arm
should allow for calculations of feasibility and standardized
effect sizes that are small to medium [60,61]. Power
calculations, based on repeated measures, within – between
comparisons among 3 groups for a single measure across two
occasions, indicated that a total sample size of 30 would provide
a power of 0.8 to detect an effect size of 0.3. Participants will
be assigned to an intervention or control group based on the site
from which they have been recruited to avoid contamination.
Participants will meet with the researcher at a time convenient
to them, to complete a battery of baseline questionnaires, which
consists of SDM measures, the experience of service, and
decisional conflict measures. Participants will have the choice
to complete these online or using paper and pencil. Depending
on which group the participants belong to (IG1 and IG2), they
will receive help to access the app and be given a guided tour
of the app. The parent will then go away and use the app as
much as they need to. Participants will complete follow-up
measures about 3 months after or at dropout/discharge
(whichever comes first).
Clinicians will also complete an adapted version of the Control
Preferences Scale (CPS) for us to obtain their perspective on
changes in the amount of parental involvement in the child’s
care and treatment decisions. It may also be important for
clinicians to report any changes in the length of appointments
or missed appointments and improvements in a child’s mental
health.
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At the end of the pilot-testing phase, participants will share their
opinions on the study and, more specifically, on the intervention
used and will then be debriefed and thanked for their
participation.
Outcome Measures
Stage 1 (Development Stage)
Demographic Characteristics
Participants will be asked both categorical (eg, gender, ethnicity,
first language, and relationship to child) and continuous (eg,
age) demographics. Demographic data on the patient population
will also be collected. This will determine the profile of the
families and health care professionals participating in the study.
Interview Topic Guide
The focus groups and interviews will follow a topic guide that
aims to allow participants to review the current prototype of
PUfP and provide feedback on all aspects of the prototype.
Feedback will inform content and design while exploring the
decision-making approaches of parents and clinicians. The topic
guide will also explore parents’ emotions and how they impact
the decision-making process. These interviews and focus groups
are expected to provide preliminary qualitative input on the
acceptability and usefulness of PUfP.
Stage 2 (Pilot-Testing Stage)
Participation Numbers
The number of sites that are approached and the number of sites
agreeing to take part will be recorded, in addition to the number
of participants agreeing to take part in the study. The proportion
of participants completing various parts of the study (ie, consent,
pretest, intervention, and posttest) will also be recorded. The
app usage rates will also be collected using Google Analytics
software.
The Control Preferences Scale for Pediatrics
The Control Preferences Scale for Pediatrics (CPS-P) [62] is
an adaptation of the CPS [63]. This tool was originally
developed to measure “the degree of control an individual wants
to assume when decisions are being made about medical
treatment” [64]. The CPS-P consists of 5 different scenarios
describing different levels of control preference in decision
making. The original scale has been tested in a variety of
populations, ranging from the general public to highly stressed
groups. The CPS has proven to be a clinically relevant, easily
administered, valid, and reliable measure of preferred roles in
health care decision making [64]. Permission was obtained to
modify and reproduce the CPS-P. Therefore, we also adapted
the questionnaire to obtain clinicians’ perspectives on how
parents preferred to be involved in decisions. Clinicians will be
asked to select 1 of 5 statements on whether “the parent leaves
all mental health care and treatment decisions about the child
to the practitioner” or “the parent shared responsibility for the
mental health care and treatment decisions about the child with
the practitioner.”
Pediatric Shared Decision-Making Questionnaire
The 9-item Pediatric Shared Decision-Making Questionnaire
(PSDM-Q-9)—Parent (modified) version measures the extent
to which parents are involved in the process of decision making
from the perspective of the parent. The measure was developed
for use in research and clinical practice. This tool is commonly
used for the purposes of evaluation and quality improvement
in health care. This measure is being applied in the case of
preference-sensitive decisions—that is, when there are several
options to be considered before a particular decision is made.
This measure has shown face validity and high acceptance.
Internal consistency yielded a Cronbach alpha of .938 in a test
sample [65].
Spielberger State Anxiety Inventory Form for Adults
The Spielberger State Anxiety Inventory Form for Adults
(STAI-AD) is a 40-item self-reported questionnaire commonly
used as a measure of trait and state anxiety. It is used in research
as an indicator of caregiver distress. The STAI-AD internal
consistency coefficients ranged from .86 to .95; test-retest
reliability coefficients ranged from .65 to .75 over a 2-month
interval [66]. In addition, test-retest coefficients for this measure
in another study are rated as highly significant with an intraclass
correlation coefficient ranging from .39 to .89 [67].
Decisional Conflict Scale
The 16-item Decisional Conflict Scale was developed to elicit
information concerning the decision maker’s (1) uncertainty in
making a choice; (2) modifiable factors contributing to the
uncertainty, such as lack of information, unclear values, and
inadequate social support; and (3) perceived effective decision
making [68]. This scale quantifies factors that contribute to
uncertainty both during the process and at the outcome. Previous
studies have shown that the psychometric properties of the scale
are acceptable, and it is feasible and easy to administer [68].
Experience of Service Questionnaire
The Experience of Service Questionnaire (ESQ) measures
service satisfaction and is widely used in CAMHS in the United
Kingdom. The ESQ consists of 12 items and 3 free-text sections
looking at what the respondents liked about the service, what
they felt needed improving, and any other comments. The
satisfaction with care construct will be obtained by adding up
items 1 to 7, 11, and 12 [69]. These constructs are important to
the study as the SDM process and outcome may impact parents’
perception of service satisfaction. On the basis of literature
reviews of SDM [70], the research team agreed that the
following questions also assess the key components of SDM:
(1) I feel that the people who have seen my child listened to
me; (2) It was easy to talk to the people who have seen my child;
(4) My views and worries were taken seriously and (6) I have
been given enough explanation about the help available here
[40].
The Post-Study System Usability Questionnaire
The Post-Study Usability Questionnaire (PSSUQ) is a 19-item
usability quantification survey developed in 1992 by the IBM
Design Centre. The PSSUQ is generally used to quantify the
usability of websites, apps, or any software or hardware that
users interact with. The questionnaire is a series of statements
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describing the app that users agree or disagree with using a
Likert scale [71]. For this study, the more general term system
was replaced with the word app, and therefore, questions were
more targeted, such as “I was able to complete the tasks and
scenarios quickly using this app.” This measure aims to further
assess the usability, appropriateness, acceptability, and
feasibility of the overall intervention.
Planned Analysis
Stage 1: Development Stage
Data collected from focus groups and interviews will be
analyzed using thematic analysis [72]. Themes will inform the
development stage of the intervention by providing the relevant
material to inform the content and design of the final version
of PUfP. All interviews and focus group sessions will be
audio-recorded digitally and transcribed. The computer package
Atlas.ti or NVivo will be used to manage the data. Data will be
coded using a combination of a priori themes and emergent
themes [73].
Stage 2: Pilot-Testing Stage
The data collected will be analyzed with the main aim to reflect
on potential improvements to the content of the intervention
and informing the overall study design for a prospective RCT.
The correlation between demographic data, app use, and
outcome measures will be explored to identify target groups.
Qualitative and quantitative evaluations will be carried out to
examine the acceptability of the intervention as a useful decision
aid for parents of children accessing CAMHS. In addition,
between-group mean differences at the 2 time points (ie, baseline
and follow-up) will be conducted. The standard deviations and
intraclass correlation coefficients of the SDM measure will
identify the parameters to enable planning for the subsequent
trial. The outcome of these analyses will be used to calculate
the sample size for the future RCT. Analyses will be conducted
using the SPSS software and mostly presented descriptively.
The main focus will be on descriptive data, with some
exploratory significance testing. The amount of missing data
will also be reported for each group.
Outcomes from stages 1 and 2 will be tested against a
predetermined set of criteria. Multimedia Appendix 2
summarizes the criteria for assessing the feasibility of a
prospective RCT upon completion of the feasibility trial.
Risk Register
Ethical Approvals, Research Governance, and Study
Sponsorship
This research project has been ethically reviewed by the London
Surrey Research Ethics Committee and approved by the Health
Research Authority (IRAS 236277). This study will also be
guided by UCL Ethical Standards, the Declaration of Helsinki
(2008), the International Conference on Harmonisation Good
Clinical Practice, and conducted in accordance with the
Department of Health Research Governance Framework for
Health and Social Care (April 2005) and the Data Protection
Act (2018).
Confidentiality
Interview and focus group recordings will be held securely on
a password-protected server at the evidence-based practice unit
(using the Data Safe Haven system) until the recording has been
transcribed, at which point the recording will be deleted.
Transcripts will be held securely under a uniquely identifiable
number on the Data Safe Haven system and will be anonymized
at the point of transcription. Consent forms will also be kept in
secure locked storage, separate from the research data. Anything
containing names and contact details will be stored separately
and securely from the research data. The data collected during
the pilot-testing stage in questionnaire format will only be
identifiable by a unique number and will also be kept securely.
All paper documents will be kept in secure locked storage, and
once the data have been entered into an electronic state, the
paper versions will then be shredded and disposed of according
to UCL’s standards for disposing of confidential waste.
Appropriate access controls will be in place to ensure that access
to confidential research information is restricted to the main
researcher (SL) and immediate supervisors (JEC and MW). All
data will be collected, handled, and stored in accordance with
local and national information governance procedures, including
the Data Protection Act (2018).
Safeguarding
To protect both the participants and researchers, safeguarding
procedures of UCL/AFNCCF, in addition to the NHS site
procedures, will be strictly adhered to. Safeguarding protocols
will be followed if at any point of the research a participant
reveals information that suggests he/she is of serious risk to
themselves or others. If any participant becomes distressed or
too emotional during the interviews, they will be treated with
compassion and empathy by trained/experienced researchers
and signposted to further help if necessary. The content of the
questionnaires have been reviewed to ensure that the
standardized measures that are least likely to cause further
burden are selected.
Recruitment
Parents and clinicians will need to set aside time for participating
in interviews/focus groups. The researchers will remain flexible,
and parent participants will be offered prospective travel
reimbursement where necessary. Participation will remain
voluntary to avoid any burden to participants, and all participants
at every stage will be required to give informed consent. Details
of their role in the study will be given both orally and via the
information sheets, and all questions will be addressed.
Participants can opt out at any stage of the study if they feel
uncomfortable.
Intervention
The actual use of the app may become an inconvenience for the
parent or clinician. Owing to the co-design approach taken, the
features should be something that parents are interested in using.
By taking this approach, it is less likely that the use of the app
will be seen as an inconvenience. In addition, clinicians are
allowed to be flexible with the use of the prototype during
sessions and therefore can manage any time strains.
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Results
Recruitment began in January 2019 and is scheduled to last for
10 months. Interviews and baseline data collection are currently
in progress, and to date, 11 CAMH sites have been recruited to
take part in the study. It is anticipated that data collection will
be completed by October 2019.
Discussion
To our knowledge, this is the first feasibility study to pilot-test
an interactive parent-targeted digital SDM tool across CAMHS
in England. This 2-stage research project and its findings will
inform the development and testing of a parent-targeted SDM
Web app to be used in CAMHS. It will target parents/primary
caregivers of children seeking various mental health services.
PUfP is expected to offer the necessary support parents need
when making decisions for/with children with mental health
challenges.
One advantage to this study’s approach is that parents and
clinicians themselves get to shape a tool that caregivers,
clinicians, and other service providers and users may access in
the future. Participants may find taking part in research to be
rewarding, as they contribute to the development of knowledge
that may benefit themselves and others. Parents will feel
supported and empowered to make informed choices and feel
included in the SDM process alongside their child and the health
professionals. This approach coincides with the National
Institute for Health and Care Excellence guidelines on service
users having the right to be involved in discussions about
treatment and care [25]. This research will have implications
for the use and implementation of digital interventions within
the NHS and future research in the area of SDM as a triad
process in CAMHS.
Finally, the findings from this feasibility study will inform the
planning of a prospective RCT. The larger study will add to this
initial understanding of how the implementation of PUfP can
aid in the promotion of SDM in CAMHS while reducing parents'
feeling of exclusion from the decision-making process. The
prospective RCT may also be able to highlight other areas PUfP
can impact, for example, on decreasing waiting times if parents
have quicker access to support. This study and the prospective
RCT can have research, policy, and practice implications for
how SDM is managed in CAMHS with the use of technological
interventions.
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